Company / Cost of Revenue
Illumina, Inc. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$1.5B
FY2025
5-year range
$1.0B / $1.8B
FY2021-FY2025
Trend
-2.5%
vs FY2024
Sector context
#37 of 113
Health Care
What the data says
At $1.5B, Illumina, Inc.'s cost of revenue ranks #77 of 113 in the Health Care sector. Cost of Revenue has fluctuated over the past 10 years, ranging from $671M in FY2017 to $1.8B in FY2023.
Based on SEC 10-K filings.
$1.5B in FY2025 with a 5-year CAGR of +7.3%.
Improved from $1.8B to $1.5B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +12.4%
- 5-Year CAGR
- +7.3%
- 10-Year CAGR
- -
Sector benchmark
#77 of 113 in Health CareTop 67% of 113This company $1.5B Sector average $11.3B
▼
-87.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.3%, indicating consistent growth.
- In FY2025, cost of revenue decreased 2.5% year-over-year.
- Ranks #37 out of 113 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5B | -2.5% |
| FY2024 | $1.5B | -14.1% |
| FY2023 | $1.8B | +69.9% |
| FY2022 | $1.0B | -24.5% |
| FY2021 | $1.4B | +32.4% |
| FY2020 | $1.0B | +11.9% |
| FY2019 | $926.0M | +26.5% |
| FY2018 | $732.0M | +9.1% |
| FY2017 | $671.0M | -8.3% |
| FY2016 | $732.0M | +9.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026